Histamine in cancer immunology and immunotherapy : current status and new perspectives
Abstract: Cancer is the second leading cause of death globally and its incidence and mortality are rapidly increasing worldwide. The dynamic interaction of immune cells and tumor cells determines the clinical outcome of cancer. Immunotherapy comes to the forefront of cancer treatments, resulting...
Autores principales: | , , , |
---|---|
Formato: | Artículo |
Lenguaje: | Inglés |
Publicado: |
British Pharmacological Society
2022
|
Materias: | |
Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/15128 |
Aporte de: |
id |
I33-R139-123456789-15128 |
---|---|
record_format |
dspace |
institution |
Universidad Católica Argentina |
institution_str |
I-33 |
repository_str |
R-139 |
collection |
Repositorio Institucional de la Universidad Católica Argentina (UCA) |
language |
Inglés |
topic |
CANCER DE MAMA INMUNIDAD ADAPTATIVA INMUNIDAD ANTITUMORAL RECEPTORES DE HISTAMINA INMUNOTERAPIA INMUNIDAD INNATA LEUCEMIA |
spellingShingle |
CANCER DE MAMA INMUNIDAD ADAPTATIVA INMUNIDAD ANTITUMORAL RECEPTORES DE HISTAMINA INMUNOTERAPIA INMUNIDAD INNATA LEUCEMIA Sarasola, María de la Paz Táquez Delgado, Mónica Alejandra Nicoud, Melisa Beatriz Medina, Vanina Araceli Histamine in cancer immunology and immunotherapy : current status and new perspectives |
topic_facet |
CANCER DE MAMA INMUNIDAD ADAPTATIVA INMUNIDAD ANTITUMORAL RECEPTORES DE HISTAMINA INMUNOTERAPIA INMUNIDAD INNATA LEUCEMIA |
description |
Abstract: Cancer is the second leading cause of death globally and its incidence and mortality
are rapidly increasing worldwide. The dynamic interaction of immune cells and tumor
cells determines the clinical outcome of cancer. Immunotherapy comes to the forefront
of cancer treatments, resulting in impressive and durable responses but only in
a fraction of patients. Thus, understanding the characteristics and profiles of immune
cells in the tumor microenvironment (TME) is a necessary step to move forward in the
design of new immunomodulatory strategies that can boost the immune system to
fight cancer. Histamine produces a complex and fine-tuned
regulation of the phenotype
and functions of the different immune cells, participating in multiple regulatory
responses of the innate and adaptive immunity. Considering the important actions
of histamine-producing
immune cells in the TME, in this review we first address the
most important immunomodulatory roles of histamine and histamine receptors in the
context of cancer development and progression. In addition, this review highlights
the current progress and foundational developments in the field of cancer immunotherapy
in combination with histamine and pharmacological compounds targeting
histamine receptors. |
format |
Artículo |
author |
Sarasola, María de la Paz Táquez Delgado, Mónica Alejandra Nicoud, Melisa Beatriz Medina, Vanina Araceli |
author_facet |
Sarasola, María de la Paz Táquez Delgado, Mónica Alejandra Nicoud, Melisa Beatriz Medina, Vanina Araceli |
author_sort |
Sarasola, María de la Paz |
title |
Histamine in cancer immunology and immunotherapy : current status and new perspectives |
title_short |
Histamine in cancer immunology and immunotherapy : current status and new perspectives |
title_full |
Histamine in cancer immunology and immunotherapy : current status and new perspectives |
title_fullStr |
Histamine in cancer immunology and immunotherapy : current status and new perspectives |
title_full_unstemmed |
Histamine in cancer immunology and immunotherapy : current status and new perspectives |
title_sort |
histamine in cancer immunology and immunotherapy : current status and new perspectives |
publisher |
British Pharmacological Society |
publishDate |
2022 |
url |
https://repositorio.uca.edu.ar/handle/123456789/15128 |
work_keys_str_mv |
AT sarasolamariadelapaz histamineincancerimmunologyandimmunotherapycurrentstatusandnewperspectives AT taquezdelgadomonicaalejandra histamineincancerimmunologyandimmunotherapycurrentstatusandnewperspectives AT nicoudmelisabeatriz histamineincancerimmunologyandimmunotherapycurrentstatusandnewperspectives AT medinavaninaaraceli histamineincancerimmunologyandimmunotherapycurrentstatusandnewperspectives |
bdutipo_str |
Repositorios |
_version_ |
1764820525527334912 |